Unicycive Therapeutics, Inc.
A biotechnology company focused on developing novel treatments for kidney disease, developing candidates for the treatment of hyperphosphatemia in patients with chronic kidney disease and acute kidney injury. Leveraging its expertise and past success in the biopharmaceutical industry, the company aims to license technologies and drugs, develop products, and commercialize them. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 14 |
Founded | 2016 |
Financials | |
|---|---|
Market Capitalization | 42.40M |
Revenue | |
Operating Income | -25.78M |
Operating Margin | |
Net Income | -37.81M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4098 / 5373 |
Sector : Healthcare | 563 / 1144 |
Industry : Biotechnology | 223 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4625 / 5565 |
Sector : Healthcare | 844 / 1182 |
Industry : Biotechnology | 466 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4174 / 5436 |
Sector : Healthcare | 644 / 1164 |
Industry : Biotechnology | 294 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4895 / 5330 |
Sector : Healthcare | 999 / 1174 |
Industry : Biotechnology | 525 / 667 |